 |
What Nephrologists Need to Know About Gadolinium CME DisclosuresRelease Date: November 15, 2007; Valid for credit through November 15, 2008 |
| Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians | |
| Contents of This CME Activity | |
| Gadolinium has been considered a very safe contrast agent for patients undergoing MRI, to the point that physicians use gadolinium for nonapproved indications. The current review reexamines the safety of gadolinium and reports on some significant complications associated with this agent. - What Nephrologists Need to Know About Gadolinium
Jeffrey G. Penfield, MD
Robert F. Reilly, Jr., MD
Go to Test Questions |
| Legal Disclaimer | |
| The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity. Copyright © 2007 Medscape |
|
|
 |
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Contact This Provider
|
|
